A new intracellular serine protease inhibitor expressed in the rat pituitary gland complexes with granzyme B

被引:6
作者
Hill, RM
Morresey, KS
Coates, LC
Mezey, E
Fell, B
Bratt, T
Trapani, JA
Birch, NP
机构
[1] Univ Auckland, Sch Biol Sci, Mol Neuroendocrinol Grp, Auckland 1, New Zealand
[2] NINDS, Basic Neurosci Program, NIH, Bethesda, MD 20892 USA
[3] Austin Res Inst, Cellular Cytotox Lab, Heidelberg, Vic, Australia
关键词
inhibitor; pituitary; serpin; serine protease; granzyme B;
D O I
10.1016/S0014-5793(98)01475-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have cloned a novel serpin (raPIT5a) from a rat pituitary cDNA library which is structurally related to members of the ovalbumin subfamily of serine protease inhibitors. This new cDNA encodes a 374-amino acid protein, designated raPIT5a. raPIT5a was expressed in specific cells in the intermediate and anterior lobes of the pituitary. Recombinant raPIT5a was not secreted suggesting raPIT5a functions to inhibit intracellular proteases, Recombinant raPIT5a formed an SDS-stable complex with human granzyme B, a serine protease which induces apoptosis by activating members of the caspase enzyme family. These data suggest raPIT5a may have a role in regulating granzyme B or related enzymes and apoptosis in the pituitary gland. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:361 / 364
页数:4
相关论文
共 25 条
[1]   NATURAL PROTEIN PROTEINASE-INHIBITORS AND THEIR INTERACTION WITH PROTEINASES [J].
BODE, W ;
HUBER, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02) :433-451
[2]   PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS [J].
BOOTH, NA ;
SIMPSON, AJ ;
CROLL, A ;
BENNETT, B ;
MACGREGOR, IR .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (03) :327-333
[3]   STRUCTURE AND VARIATION OF HUMAN ALPHA-1-ANTITRYPSIN [J].
CARRELL, RW ;
JEPPSSON, JO ;
LAURELL, CB ;
BRENNAN, SO ;
OWEN, MC ;
VAUGHAN, L ;
BOSWELL, DR .
NATURE, 1982, 298 (5872) :329-334
[4]   CLONING AND MOLECULAR CHARACTERIZATION OF A HUMAN INTRACELLULAR SERINE PROTEINASE-INHIBITOR [J].
COUGHLIN, P ;
SUN, JR ;
CERRUTI, L ;
SALEM, HH ;
BIRD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (20) :9417-9421
[5]   DETECTION AND PARTIAL CHARACTERIZATION OF AN INHIBITOR OF PLASMINOGEN-ACTIVATOR IN HUMAN-PLATELETS [J].
ERICKSON, LA ;
GINSBERG, MH ;
LOSKUTOFF, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) :1465-1472
[6]   EFFECTS OF PROTEOLYTIC-ENZYMES AND PROTEASE INHIBITORS ON BOVINE THYROID ADENYLATE-CYCLASE ACTIVITY [J].
FRIEDMAN, Y ;
WILGER, J ;
CROWELL, D ;
BURKE, G .
ENDOCRINOLOGY, 1983, 112 (05) :1674-1679
[7]   PROTEASES AND THE EMERGING ROLE OF PROTEASE INHIBITORS IN PROHORMONE PROCESSING [J].
HOOK, VYH ;
AZARYAN, AV ;
HWANG, SR ;
TEZAPSIDIS, N .
FASEB JOURNAL, 1994, 8 (15) :1269-1278
[8]  
HOPKINS PCR, 1994, SCIENCE, V265, P1893
[9]   IMPLICATIONS OF THE 3-DIMENSIONAL STRUCTURE OF ALPHA-1-ANTITRYPSIN FOR STRUCTURE AND FUNCTION OF SERPINS [J].
HUBER, R ;
CARRELL, RW .
BIOCHEMISTRY, 1989, 28 (23) :8951-8966
[10]   PLASMA-LEVELS OF A SPECIFIC INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (AND UROKINASE) IN NORMAL AND PATHOLOGICAL CONDITIONS [J].
JUHANVAGUE, I ;
MOERMAN, B ;
DECOCK, F ;
AILLAUD, MF ;
COLLEN, D .
THROMBOSIS RESEARCH, 1984, 33 (05) :523-530